Little Chesterford, United Kingdom

Philip Fallon

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medivir Ab. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Fallon. Retrieved from https://idiyas.com/inventor/philip-fallon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Work of Inventor Philip Fallon

Introduction

Philip Fallon, an accomplished inventor based in Little Chesterford, GB, has made a significant contribution to the field of biochemistry. His innovative work primarily focuses on cysteine protease inhibitors, a crucial area that has implications in various therapeutic applications.

Latest Patents

Philip Fallon holds one patent, which revolves around cysteine protease inhibitors. The patent details a compound of the formula II, showcasing his expertise and commitment to advancing scientific knowledge in this vital area of research.

Career Highlights

Currently, Philip Fallon works at Medivir AB, where he continues to explore innovative solutions in the pharmaceutical sector. His role at Medivir AB allows him to apply his knowledge and creativity to develop novel compounds that could potentially lead to new treatments.

Collaborations

Philip collaborates with esteemed colleagues in his field, including Magnus Nilsson and Xiao-Xiong Zhou. These partnerships enhance the innovative outcomes of their projects and contribute to a collaborative research environment focused on groundbreaking discoveries.

Conclusion

In conclusion, Philip Fallon represents the spirit of innovation within the biochemistry field. With his patent for cysteine protease inhibitors and his collaborative efforts at Medivir AB, he continues to pave the way for future advancements in therapeutic solutions. His work exemplifies the importance of creativity and teamwork in the pursuit of scientific breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…